The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world PROCEED registry data: Sipuleucel-T in elderly men with metastatic castration-resistant prostate cancer (mCRPC).
 
Andrew J. Armstrong
Honoraria - Dendreon; Janssen Oncology; Sanofi
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Dendreon; Sanofi
Research Funding - Active Biotech (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc; Bayer; Dendreon; Janssen Biotech
 
Carl A Olsson
Stock and Other Ownership Interests - Egenix; Exelixis (I)
Research Funding - Advantagene (Inst); Dendreon (Inst); Medivation (Inst)
Other Relationship - American Urological Association
 
Ian D. Schnadig
Employment - Compass Oncology; McKesson
Leadership - Compass Oncology
Travel, Accommodations, Expenses - Compass Oncology; McKesson
 
Raoul S Concepcion
Consulting or Advisory Role - Genomic Health; IntegraConnect
Speakers' Bureau - Amgen; Astellas Medivation; AstraZeneca; Dendreon; Janssen Oncology; Sanofi
 
Jeffrey L. Vacirca
Employment - New York Cancer and Blood Specialists
Leadership - Odonate Therapeutics
Stock and Other Ownership Interests - Odonate Therapeutics
 
Ronald F Tutrone
Stock and Other Ownership Interests - Novartis; Nymox; Sophiris Bio
Consulting or Advisory Role - 3D Biopsy; Medivation/Astellas; Pfizer
Speakers' Bureau - Dendreon; Medivation/Astellas
Research Funding - Advaxis (Inst); Allena Pharmaceuticals (Inst); Allergan (Inst); American Medical Systems (Inst); Bayer (Inst); Boston Scientific (Inst); Genentech/Roche (Inst); Genomic Health (Inst); Janssen Oncology (Inst); MDxHealth (Inst); Medivation/Astellas (Inst); Mundipharma (Inst); Neotract (Inst); Nymox (Inst); Sophiris Bio (Inst)
 
Shaker R. Dakhil
No Relationships to Disclose
 
Nancy N. Chang
Employment - Dendreon
 
Hong Tang
Employment - Astellas Scientific and Medical Affairs Inc; Dendreon; Juno Therapeutics
Stock and Other Ownership Interests - Astellas Scientific and Medical Affairs Inc; Bauerfeind; Bristol-Myers Squibb; CVS; Dendreon; Juno Therapeutics; Marathon Pharma; Nektar; Sangamo Bioscience; Tesaro; Verastem
 
Bruce Brown
Employment - Astellas Medivation; Dendreon
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Pfizer; UpToDate
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Caris Life Sciences; Fujifilm; Genentech/Roche; HERON; Pfizer; Tolero Pharmaceuticals
Speakers' Bureau - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Sanofi
Research Funding - Endocyte (Inst); Merck (Inst); Suzhou Kintor Pharmaceuticals (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer/Onyx; Exelixis; Genentech/Roche; Pfizer; US Oncology